Neil F. McFarlane, President and CEO: Zevra Therapeutics ZVRA Planned sale · Filed 02/02

Trade details

Type: Planned sale notice
Stock: Zevra Therapeutics ZVRA
Person: Neil F. McFarlanePresident and CEO
Planned sale date: 26/02/02
Filed: 26/02/02

0.2% of shares outstanding to be sold

Zevra Therapeutics trades, last 26 weeks

What else happened in Zevra Therapeutics around then

Filed or reported within 30 days of the trade day · 01/03~03/04

Neil F. McFarlane's recent trades

Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$125.2K
14,625 sh
$125.2K
Filed 02/10
Traded 02/09
Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$853.6K
91,000 sh
$853.6K
Filed 02/02
Traded 02/02
Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$211K
19,500 sh
$211K
Filed 25/10/10
Traded 25/10/10
Neil F. McFarlanePresident and CEO
Planned sale10b5-1 planZevra Therapeutics
Planned sale10b5-1 plan
Zevra Therapeutics
ZVRA
$211K
19,500 sh
$211K
Filed 25/10/10
Traded 25/10/10
Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$481.6K
61,273 sh
$481.6K
Filed 25/02/14
Traded 25/02/13

Neil F. McFarlane, CEO — plans to sell 105,625 sh of Zevra Therapeutics ZVRA · $950.6K · around 02/02 · 10b5-1 plan | Whalegun